To rule out cell line- or method-dependent phenomena, the data obtained in DLD1 cells were confirmed in a BRCA2-complementation model established by Wang et al. [38], employing the pancreatic cancer cell line CAPAN1. The gene discussed is BRCA2; the disease is familial pancreatic carcinoma.